skip navigation nih record
Vol. LXII, No. 17
August 20, 2010
cover

previous story



Volunteers

The phone numbers for more information about the studies below are 1-866-444-2214 (TTY 1-866-411-1010) unless otherwise noted.

Januvia Study

Volunteers are needed for a study examining the immune function in healthy volunteers given short-term treatment of sitagliptin. Investigators wish to determine if and how sitagliptin alters immune function. If you are 18 years or older and healthy, consider participating in this study. All study-related tests are provided at no cost. Compensation is provided. Refer to study 09-DK-0055.

Asthma Study for Adults 18 to 65

You may be eligible to participate in a clinical research study of the drug DAS 181. The investigational drug is currently being studied as a potential treatment for the flu. The goal of the study is to determine if DAS 181 can safely be given to individuals with well-controlled asthma. The study will last between 6-12 weeks and there are a total of 12 visits required. In order to participate, you must have had well-controlled asthma for at least the past 3 months, not be allergic to milk or milk products and not be taking oral corticosteroids. Compensation is provided. Refer to study 10-I-0085.

Bronchiectasis Study for Adults 18 to 65

You may be eligible to participate in a clinical research study of the drug DAS 181. The investigational drug is currently being studied as a potential treatment for the flu. The goal of the study is to determine if DAS 181 can safely be given to individuals with bronchiectasis. The study will last between 6-12 weeks and there are a total of 12 visits required. In order to participate, you must have had a chest CT scan within the last 12 months that establishes a diagnosis, not be allergic to milk or milk products and not be taking corticosteroids. Compensation is provided. Refer to study 10-I-0085.

Macular Degeneration Study

We are seeking patients with wet age-related macular degeneration. The Food and Drug Administration has approved the use of Lucentis for treatment of this ailment. The National Eye Institute is looking for volunteers ages 50 and older with the ailment to participate in a study exploring the different responses to Lucentis. Participants will be required to travel to NIH on an outpatient basis for the initial evaluation and subsequent monthly examinations. Refer to study 08-EI-0103.

back to top of page